Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Current WSJ MEDIF book value per share - .14

<< Previous

Bullboard Posts

Next >>

Comment by unplugged1on Dec 16, 2023 10:18pm

85 Views

Post# 35788565

RE:Current WSJ MEDIF book value per share - .14

now I can respond all-a-sudden! I swear i'm not screwin around!
What are you showing us here MJ,? I clicked on one of em', 0.20c book value on the link I clicked if so, stellar post mate. 0.20 current value in today's market sentiment sound far more reasonable.
But if the states do something with CBD regulation we're a rocket ship. 'Blue Sky'

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide